Xanthine Oxidase Is Involved in Free Radical Production in Type 1 Diabetes

Diabetes - Tập 51 Số 4 - Trang 1118-1124 - 2002
Carmen Desco1, Miguel Asensi1, Rafael Marquéz1, J Martínez-Valls2, Máximo Vento1, Federico V. Pallardó1, Juan Sastre1, José Viña1
1Department of Physiology, Faculty of Medicine, University of Valencia, Valencia, Spain
2Department of Endocrinology, University Clinic, Valencia, Spain

Tóm tắt

The aim of this work was to study the mechanism of free radical formation in type 1 diabetes and its possible prevention. We have found oxidation of blood glutathione and an increase in plasma lipoperoxide levels in both human type 1 diabetes and experimental diabetes. Peroxide production by mitochondria does not increase in diabetes. On the contrary, the activity of xanthine oxidase, a superoxide-generating enzyme, increases in liver and plasma of diabetic animals. The increase in plasma xanthine oxidase activity may be explained by the increase in the hepatic release of this enzyme, which is not due to nonspecific membrane damage: release of other hepatic enzymes, such as the amino transferases, does not increase in diabetes. Superoxide formation by aortic rings of rabbits increases significantly in diabetes. This is completely inhibited by allopurinol, an inhibitor of xanthine oxidase. Heparin, which releases xanthine oxidase from the vessel wall, also decreases superoxide formation by aortic rings of diabetic animals. Treatment with allopurinol decreases oxidative stress in type 1 diabetic patients: hemoglobin glycation, glutathione oxidation, and the increase in lipid peroxidation are prevented. These results may have clinical significance in the prevention of late-onset vascular complications of diabetes.

Từ khóa


Tài liệu tham khảo

Baynes J: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412,1991

Sies H: Angewandte Chem 25:1058–1071,1986

Oberley LW: Free radicals and diabetes. Free Rad Biol Med 5:113–124,1988

Wolff SP: Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 49:642–652,1993

Hunt JV, Dean RT, Wolff SP: Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256:205–212,1988

Jain SK, Mc Vie R, Jaramillo JJ, Chen Y: Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in type-I diabetic patients. Free Rad Biol Med 24:175–181,1998

Jain SK, Kannan K, Lim G: Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Rad Biol Med 25:1083–1088,1998

Jain SK, McVie R, Jackson R, Levine SN, Lim G: Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients. Diabetes Care 22:1171–1175,1999

Viña J, Hems R, Krebs HA: Maintenance of glutathione content in isolated hepatocytes. Biochem J 170:627–630,1978

Asensi M, Sastre J, Pallardó FV, Estrela J, Viña J: Determination of oxidized glutathione in blood: high-performance liquid chromatography. Methods Enzymol 234:367–371,1994

Asensi M, Sastre J, Pallardó FV, García de la Asunción J, Estrela JM, Viña J: A high-performance liquid chromatography method for measurement of oxidized glutathione in biological samples. Anal Biochem 217:323–328,1994

Bergmeyer HU: Methods of Enzymatic Analysis, 2nd ed. New York, Academic Press,1974

Beckman JS, Parks DA, Pearson JD, Marshall PA, Freeman BA: A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Rad Biol Med 6:607–615,1989

Richard MJ, Guiraud P, Meo J, Favier A: High-performance liquid chromatographic separation of malondialdehyde-thiobarbituric acid adduct in biological materials (plasma and human cells) using a commercially available reagent. J Chromatogr 577:9–18,1992

White CR, Darley-Ushmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, Parks DS, Tarpey MM, Freeman BA: Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci U S A 93:8745–8749,1996

Rickwood DW, Wilson MT, Darley-Usmar VM: Isolation and characteristics of intact mitochondria. In Mitochondria: A Practical Approach. Darley-Ulmar VM, Wilson MT, Rickwood D, Eds. Oxford, Washington, IRL Press,1987, p.4–6

Viña JR, Sáez GT, Viña J: The physiological functions of glutathione. In CRC Handbook of Free Radicals and Antioxidants in Biomedicine. Miguel J, Quintanilha AT, Weber H, Eds. Boca Raton, FL, CRC Press,1989, p.121–132

Miguel J, Economos AC, Fleming J, Johnson JE Jr: Mitochondrial role in cell aging. Exp Gerontol 15:575–591,1980

Sastre J, Pallardó FV, Plá R, Pellín A, Juan G, O’Connor E, Estrela JM, Miguel J, Viña J: Aging of the liver: age-associated mitochondrial damage in intact hepatocytes. Hepatology 24:1199–1205,1996

García de la Asunción J, Millán A, Plá R, Bruseghini L, Esteras A, Pallardó FV, Sastre J, Viña J: Mitochondrial glutathione oxidation correlates with age-associated oxidative damage to mitochondrial DNA. FASEB J 10:333–338,1996

Linnane A, Marzuki S, Ozawa T, Tanaka M: Mitochondrial DNA mutations as an important contributor to aging and degenerative diseases. Lancet i:642–645,1989

García de la Asunción J, Del Olmo ML, Sastre J, Millán A, Pellín A, Pallardó FV, Viña J: AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins. J Clin Invest 101:1–6,1998

Heunks LM, Vina J, van Herwaarden CL, Folgering HT, Gimeno A, Dekhuijzen PN: Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Physiol 277:R1697–R1704,1999

Adachi T, Fukushima T, Usami Y, Hirano K: Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochem J 289:523–527,1993

McLennan S, Heffernan S, Wright L, Rae C, Fisher E, Yue DK, Turtle JR: Changes in hepatic glutathione metabolism in diabetes. Diabetes 40:344–348,1991

Lubec B, Hermon M, Hoeger H, Lubec G: Aromatic hydroxylation in animal models of diabetes mellitus. FASEB J 12:1581–1587,1998

Traverso N, Menini S, Odetti P, Pronzato MA, Cottalasso D, Marinari U: Lipoperoxidation in hepatic subcellular compartments of diabetic rats. Free Rad Biol Med 26:538–547,1999

Cosentino F, Hishikawa K, Katusic ZS, Luscher TF: High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96:25–28,1997

Parks DA, Granger DN: Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol Scand Suppl 548:87–99,1986

Yokoyama Y, Beckman JS, Beckman TK, Wheat JK, Cash TG, Freeman BA, Parks DA: Circulating xanthine oxidase: potential mediator of ischemic injury. Am J Physiol 258:G564–G570,1990

Cardillo C, Kilcoyne CM, Cannon RO 3rd, Quyyumi AA, Panza JA: Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 30:57–63,1997

Butler R, Morris AD, Belch JJ, Hill A, Struthers AD: Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35:746–751,2000

Thông tin
: []
Thông tin xuất bản

Diabetes

Tập 51 Số 4

1118-1124

Thông tin tác giả